QTc Prolongation Risk with Psychotropics – Psychiatry Education Forum

Clinical Case Discussion: QTc Prolongation Risk with Psychotropics

Dr. Satinderpal Kaur (Family Medicine) & Dr. Harvinder Singh (Psychiatry) will continue their discussion to integrate clinical cases from Psychiatry and Medicine.

Our 6th clinical case discussion will focus on:
1. Understanding Basics of EKG
2. What is QT and QTc interval?
3. Medical Causes for QTc Prolongation
4. Psychotropics & Non-Psychotropic causes for QTc Prolongation
5. Antipsychotics: High Risk, Moderate Risk & Low Risk
6. Antidepressants: High Risk, Moderate Risk & Low Risk
7. Other Medications: High Risk, Moderate Risk & Low Risk
8. Case Discussion

Here is one slide from this presentation comparing the

Risk of QTc Prolongation with Atypical Antipsychotics:

HALOPERIDOL (IV)

If used, prefer total cumulative dose of IV haloperidol <2 mg.
IV use of haloperidol should only be done in continuous EKG monitoring.
TdP risk (Arizona CERT)= 1.

INTERESTED IN ACCESS TO THIS & OTHER CLINICALLY RELEVANT LECTURE SERIES?

JOIN ACADEMY MEMBERSHIP:

This is a closed membership for medical professionals only.

30+ Courses/Sections: Each chapter within these sections is of direct clinical relevance for your daily practice.
Journal Club: we will post the most recently published psychiatry articles relevant to your daily clinical practice.
Clinical Case Discussion: Dr. Singh (Psychiatry) and Dr. Kaur (Family Medicine) discuss clinical cases to integrate the clinical cases from Psychiatry and Medicine.
Discussion Forum & Community: Connect with other medical professionals and discuss your difficult-to-treat clinical cases.
Essentials of Inpatient Psychiatry Book: All chapters from this book are included in the academy sections.
Goal: is to have all important clinically relevant topics in one place for ease of access.